GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | DIABLO | affects localization | EXP | | 6480464 | CTD | Bortezomib affects the localization of DIABLO protein | PMID:16024631 | DIABLO | increases expression | EXP | | 6480464 | CTD | Bortezomib results in increased expression of DIABLO mRNA; Bortezomib results in increased expression of DIABLO protein | PMID:17327374 PMID:25913414 | DIABLO | increases localization | EXP | | 6480464 | CTD | Bortezomib results in increased localization of DIABLO protein | PMID:14555532 | DIABLO | multiple interactions | EXP | | 6480464 | CTD | [alvocidib co-treated with Bortezomib] results in increased secretion of DIABLO protein; [Bortezomib co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in decreased localization of DIABLO protein; [Bortezomib co-treated with Butyrates] affects the localization of DIABLO protein; [Bortezomib co-treated with TNFSF10 protein] results in increased expression of DIABLO protein; [Bortezomib co-treated with Vorinostat] affects the localization of DIABLO protein; Bortezomib inhibits the reaction [BAX mutant form inhibits the reaction [TNFSF10 protein results in increased localization of DIABLO protein]]; Bortezomib promotes the reaction [TNFSF10 protein results in increased localization of DIABLO protein] | PMID:12893773 PMID:12902978 PMID:15039284 PMID:15070698 | |
Go Back to source page | Continue to Ontology report |